SLC34A2-ROS1(E4-E32,E4-E34,E4-E33) Fusion询价产品描述 产品数据库CBP20023R Format RNA Description N/A Technical Data Left Gene SLC34A2 Right Gene ROS1 1st of three Breakpoints SLC34A2(E4)-ROS1(E32) Left Breakpoint chr4:25665952:+ Right Breakpoint chr6:...
The fusion geneSLC34A2-ROS1(solute carrier family 34 member 2 and ROS proto-oncogene 1) plays an important role in non-small cell lung cancer (NSCLC) progression. However, whetherSLC34A2-ROS1gene can produce circRNA remains unknown. Here, we identified two novel circRNAs (F-circSR1 and F...
基因检测标准品 > RNA标准品 > SLC34A2-ROS1 Fusion融合参考品 名称 SLC34A2-ROS1 Fusion融合参考品 型号 报价 特点 科佰生物为您提供高度特征化和精准定义的诊断参考品和质控品,帮您分析实验的敏感性、特异性和稳定性,优化和验证新的肿瘤测试方法和日常监控您实验的效果。我们通过精准定位基因突变位点,定量基...
SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling. PMID: 28777670 CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations. PMID: 38070598 Overex...
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations. PMID: 38070598 Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-...
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations. PMID: 38070598 Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-...
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations. PMID: 38070598 Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-...